New trends in liver transplantation for viral hepatitis.
作者信息
Ben-Ari Z, Tur-Kaspa R
机构信息
Department of Medicine D, and the Liver Institute, Rabin Medical Center, Beilinson Campus, Petah-Tiqva, Israel.
出版信息
Am J Gastroenterol. 1997 Dec;92(12):2155-9.
PMID:9399744
Abstract
摘要
相似文献
1
New trends in liver transplantation for viral hepatitis.病毒性肝炎肝移植的新趋势
Am J Gastroenterol. 1997 Dec;92(12):2155-9.
2
Liver transplantation for chronic viral liver disease.
Hepatogastroenterology. 1998 Sep-Oct;45(23):1357-63.
3
[Treatment of pretransplant and posttransplant viral cirrhosis].[移植前及移植后病毒性肝硬化的治疗]
Gastroenterol Hepatol. 2001 Feb;24 Suppl 1:58-63.
4
Liver transplantation in chronic hepatitis B and C.慢性乙型和丙型肝炎的肝移植
J Gastroenterol Hepatol. 2000 May;15 Suppl:E172-4.
5
[Management of children with HBV or HCV infection before and after liver and/or kidney transplantation].[肝和/或肾移植前后乙肝或丙肝感染儿童的管理]
Przegl Epidemiol. 2006;60(4):685-92.
6
Liver transplantation for chronic hepatitis B and C: dilemmas and controversies.
Liver Transpl. 2002 Oct;8(10 Suppl 1):S1-2. doi: 10.1053/jlts.2002.36249.
7
Hepatitis viruses and liver transplantation: evolving trends in antiviral management.肝炎病毒与肝移植：抗病毒治疗的发展趋势
Clin Liver Dis. 2014 Aug;18(3):575-601. doi: 10.1016/j.cld.2014.05.002.
8
[Liver transplantation in patients with chronic viral hepatitis].[慢性病毒性肝炎患者的肝移植]
Rev Gastroenterol Mex. 2005 Apr-Jun;70(2):180-91.
9
Liver transplantation for viral hepatitis: the current situation.
Prog Clin Biol Res. 1993;382:377-87.
10
[Chronic hepatitis. 2: Treatment].
Dtsch Med Wochenschr. 2001 Jul 6;126(27):786-9; quiz 790-2. doi: 10.1055/s-2001-15553.
引用本文的文献
1
The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation.HBIG 在肝移植后乙型肝炎再感染预防中的作用。
Langenbecks Arch Surg. 2012 Jun;397(5):697-710. doi: 10.1007/s00423-011-0795-6. Epub 2011 May 2.
2
Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy.“低剂量”利巴韦林与干扰素α-2a联合治疗，继以干扰素α-2a单药治疗用于慢性丙型肝炎病毒感染患者，这些患者在接受干扰素α-2a单药治疗后无应答或复发。
World J Gastroenterol. 2001 Apr;7(2):222-7. doi: 10.3748/wjg.v7.i2.222.
Zotero 插件